• 0 Citations
  • 0 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where marco chiaravalli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
gemcitabine Medicine & Life Sciences
Fumarates Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Fumarate Hydratase Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Up-Regulation Medicine & Life Sciences
Cells Chemical Compounds

Research Output 2018 2018

A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

Reni, M., Zanon, S., Balzano, G., Passoni, P., Pircher, C., Chiaravalli, M., Fugazza, C., Ceraulo, D., Nicoletti, R., Arcidiacono, PG., Macchini, M., Peretti, U., Castoldi, R., Doglioni, C., Falconi, M., Partelli, S. & Gianni, L., 2018, In : European Journal of Cancer. 102, p. 95-102 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival

mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma

Drusian, L., Nigro, EA., Mannella, V., Pagliarini, R., Pema, M., Costa, ASH., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., Montorsi, F., Capitanio, U., Musco, G., Frezza, C. & Boletta, A., 2018, In : Cell Reports. 24, 5, p. 1093-1104.e6

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Fumarate Hydratase